T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Oscar Health
OSCR
$9.34B
| $63.8M | 0.01% |
4,744,902
-643,159
| -12% | -$10.4M |
|
677
Post Holdings
POST
$3.66B
| $63.4M | 0.01% |
553,644
-56,059
| -9% | -$6.39M |
|
678
Incyte
INCY
$24.4B
| $63.1M | 0.01% |
913,708
+305,264
| +50% | +$21.8M |
|
679
Wave Life Sciences
WVE
$1.04B
| $63.1M | 0.01% |
5,098,866
+1,972,262
| +63% | +$26.3M |
|
680
Eagle Materials
EXP
$6.42B
| $62.9M | 0.01% |
254,868
-588
| -0.2% | -$170K |
|
681
FTAI Aviation
FTAI
$22.5B
| $62.9M | 0.01% |
436,517
-501,928
| -53% | -$74M |
|
682
Lennox International
LII
$14.4B
| $62.8M | 0.01% |
103,042
+29,579
| +40% | +$18.5M |
|
683
Comfort Systems
FIX
$61.4B
| $62.7M | 0.01% |
147,789
-14,144
| -9% | -$6.21M |
|
684
XPO
XPO
$25.1B
| $62.6M | 0.01% |
477,349
-23,609
| -5% | -$3.19M |
|
685
Colliers International
CIGI
$5.32B
| $62.4M | 0.01% |
458,569
+4,101
| +0.9% | +$606K |
|
686
Fidelity National Information Services
FIS
$22.2B
| $62.3M | 0.01% |
771,783
+3,938
| +0.5% | +$339K |
|
687
Denali Therapeutics
DNLI
$3.99B
| $62.3M | 0.01% |
3,058,615
+188,820
| +7% | +$4.83M |
|
688
ATI
ATI
$31.2B
| $62.1M | 0.01% |
1,128,962
+5,663
| +0.5% | +$334K |
|
689
TKO Group
TKO
$14.4B
| $62.1M | 0.01% |
436,826
+13,232
| +3% | +$1.73M |
|
690
Zai Lab
ZLAB
$2.91B
| $61.7M | 0.01% |
2,354,025
+548,378
| +30% | +$15.2M |
|
691
HEICO Corp
HEI
$52.3B
| $61.4M | 0.01% |
258,390
+33,162
| +15% | +$8.59M |
|
692
NRG Energy
NRG
$25.1B
| $61.2M | 0.01% |
677,894
+368,473
| +119% | +$34.1M |
|
693
Pliant Therapeutics
PLRX
$66.9M
| $61M | 0.01% |
4,634,486
-200,327
| -4% | -$2.74M |
|
694
Performance Food Group
PFGC
$16.4B
| $61M | 0.01% |
721,853
-73,958
| -9% | -$6.24M |
|
695
Prudential Financial
PRU
$42.9B
| $61M | 0.01% |
514,702
+6,669
| +1% | +$823K |
|
696
T. Rowe Price Dividend Growth ETF
TDVG
$1.45B
| $60.4M | 0.01% |
1,525,001
+400,000
| +36% | +$16.3M |
|
697
Axalta
AXTA
$7.95B
| $60.4M | 0.01% |
1,763,973
+198,551
| +13% | +$7.47M |
|
698
Public Service Enterprise Group
PEG
$37.7B
| $60.3M | 0.01% |
713,684
+12,843
| +2% | +$1.14M |
|
699
Agnico Eagle Mines
AEM
$90.9B
| $60.2M | 0.01% |
770,178
-896,305
| -54% | -$73.9M |
|
700
Emcor
EME
$37B
| $60.2M | 0.01% |
132,541
-7,947
| -6% | -$3.76M |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.